Fig. 5From: The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysisComparison of overall response rate. a Combination therapy versus TACE. b Combination therapy versus sorafenibBack to article page